Skip to main content
TipRanks
Go Ultimate75% OFF

Ironwood Pharma (IRWD) Ownership - Who Owns Ironwood Pharma?

475 Followers

Ironwood Pharma (IRWD) Ownership Overview

  • 3.81% Insiders
  • 16.26% Mutual Funds
  • 2.20% Other Institutional Investors
  • 19.76% ETFs
  • 57.96% Public Companies and Individual Investors

The ownership structure of Ironwood Pharma (IRWD) stock is a mix of institutional, retail, and individual investors. Approximately 38.23% of the company’s stock is owned by Institutional Investors, 3.81% is owned by Insiders, and 57.96% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Mar 16, 2026Alexander Denner$20,530,448
Feb 24, 2026John Minardo$136,177
Feb 24, 2026Tammi L Gaskins$80,328
Feb 24, 2026Michael Shetzline$59,322

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Jun 30, 2026Royce & Associates Llc$78,108
Jun 30, 2026 $74,889,825

Top Shareholders

IRWD top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.17,788,557Institution10.75%86,630,273
Vanguard9,140,956Institution5.52%44,516,456
Ishares8,499,691Institution5.13%41,393,495
Vanguard Index Funds6,459,281Institution3.90%31,456,698
Spdr4,005,210Institution2.42%19,505,373
Federated Hermes Mdt Series2,018,702Institution1.22%9,831,079
Fidelity Salem Street Trust1,969,776Institution1.19%9,592,809
Thomas Mccourt1,898,838Insider1.15%9,247,341
Vanguard Horizon Funds1,833,231Institution1.11%8,927,835
Schwab1,808,847Institution1.09%8,809,085

Top Mutual Fund Holders

IRWD top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds6,459,281Institution3.90%31,456,698
Federated Hermes Mdt Series2,018,702Institution1.22%9,831,079
Fidelity Salem Street Trust1,969,776Institution1.19%9,592,809
Vanguard Horizon Funds1,833,231Institution1.11%8,927,835
Fidelity Concord Street Trust1,426,387Institution0.86%6,946,505
Vanguard Explorer Fund1,403,741Institution0.85%6,836,219
Dfa Investment Dimensions Group Inc1,304,026Institution0.79%6,350,607
Blackrock Funds1,296,137Institution0.78%6,312,187
Tiaa-cref Funds1,239,734Institution0.75%6,037,505
Vanguard Scottsdale Funds1,130,210Institution0.68%5,504,123

Top ETF Holders

IRWD top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF4,781,484Institution2.89%18,982,491
iShares Russell 2000 ETF, IWM ETF4,225,394Institution2.55%20,577,669
SPDR S&P BIOTECH ETF, XBI ETF3,448,605Institution2.08%16,587,790
Vanguard Extended Market ETF, VXF ETF1,703,600Institution1.03%6,763,292
iShares Russell 2000 Growth ETF, IWO ETF1,467,242Institution0.89%7,145,469
Pacer US Small Cap Cash Cows 100 ETF, CALF ETF1,342,152Institution0.81%6,455,751
iShares Biotechnology ETF, IBB ETF1,246,719Institution0.75%6,071,522
Dimensional U.S. Small Cap ETF, DFAS ETF1,147,361Institution0.69%5,518,806
Fidelity Enhanced Small Cap ETF, FESM ETF1,133,450Institution0.68%5,451,895
Vanguard Russell 2000 ETF, VTWO ETF950,810Institution0.57%3,774,716

FAQ

Who Owns Ironwood Pharma (IRWD)?
According to the latest TipRanks data, approximately 38.23% of the company's stock is held by institutional investors, 3.81% is held by insiders, and 57.96% is held by public companies and individual investors.
What percentage of Ironwood Pharma (IRWD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.23% of Ironwood Pharma (IRWD) stock is held by institutional investors: 16.26% by mutual funds, 19.76% by ETFs and 2.20% by other institutional investors.
What percentage of Ironwood Pharma (IRWD) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.96% of Ironwood Pharma (IRWD) stock is held by public companies and individual investors.
Who owns the most shares of Ironwood Pharma (IRWD)?
BlackRock, Inc. owns the most shares of Ironwood Pharma (IRWD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.